Lanfear Dennis M

CIK 00014208222 companiesREDWOOD CITY, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001420822

Recent Transactions

50 trades

Disposition to Issuer
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2026-05-29−402,500→ 0 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2026-05-29+400,000→ 400,000 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2026-05-29+200,000→ 200,000 total
Disposition to Issuer
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2026-05-29−225,000→ 0 total
Disposition to Issuer
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2026-05-29−402,500→ 0 total
Disposition to Issuer
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2026-05-29−200,000→ 0 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2026-05-29+225,000→ 225,000 total
Disposition to Issuer
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2026-05-29−400,000→ 0 total
Disposition to Issuer
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2026-05-29−450,000→ 0 total
Disposition to Issuer
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2026-05-29−500,000→ 0 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2026-05-29+402,500→ 402,500 total
Disposition to Issuer
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2026-05-29−500,000→ 0 total
Disposition to Issuer
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2026-05-29−125,000→ 0 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2026-05-29+402,500→ 402,500 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2026-05-29+125,000→ 125,000 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2026-05-29+500,000→ 500,000 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2026-05-29+500,000→ 500,000 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2026-05-29+450,000→ 450,000 total
Award
Coherus Oncology, Inc.$CHRS
Common Stock
2026-01-23+375,000→ 1,048,235 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2026-01-23+750,000→ 750,000 total
Tax Payment
Coherus Oncology, Inc.$CHRS
Common Stock
2026-01-20$1.55/sh−11,839→ 673,235 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2025-05-07+375,000→ 375,000 total
Tax Payment
Coherus Oncology, Inc.$CHRS
Common Stock
2025-01-20$1.39/sh−11,810→ 685,074 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2025-01-10+575,000→ 575,000 total
Tax Payment
Coherus Oncology, Inc.$CHRS
Common Stock
2025-01-04$1.66/sh−11,810→ 696,884 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2024-07-22+196,500→ 196,500 total
Tax Payment
Coherus Oncology, Inc.$CHRS
Common Stock
2024-01-20$2.44/sh−11,218→ 708,694 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2024-01-05+575,000→ 575,000 total
Tax Payment
Coherus Oncology, Inc.$CHRS
Common Stock
2024-01-04$2.92/sh−11,781→ 719,912 total
Sale
Coherus Oncology, Inc.$CHRS
Common Stock
2023-11-22$2.02/sh−223,100→ 731,693 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Common Stock
2023-11-22$1.42/sh+41,000→ 695,853 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2023-11-22−299,940→ 0 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Common Stock
2023-11-22$1.42/sh+258,940→ 954,793 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2023-06-13+225,000→ 225,000 total
Award
Coherus Oncology, Inc.$CHRS
Common Stock
2023-01-20+86,250→ 654,853 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2023-01-05+402,500→ 402,500 total
Tax Payment
Coherus Oncology, Inc.$CHRS
Common Stock
2023-01-04$9.87/sh−10,905→ 568,603 total
Gift
Coherus Oncology, Inc.$CHRS
Common Stock
2022-12-30−4,000→ 432,684 total
Award
Coherus Oncology, Inc.$CHRS
Common Stock
2022-01-04+86,250→ 579,508 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2022-01-04+402,500→ 402,500 total
Gift
Coherus Oncology, Inc.$CHRS
Common Stock
2021-11-17−10,000→ 436,684 total
Sale
Coherus Oncology, Inc.$CHRS
Common Stock
2021-06-08$13.56/sh−31,054→ 493,258 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2021-06-08−31,054→ 0 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Common Stock
2021-06-08$0.42/sh+31,054→ 524,312 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2021-06-06−300,000→ 31,054 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Common Stock
2021-06-06$0.42/sh+300,000→ 493,258 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2021-02-01+125,000→ 125,000 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2021-01-23+500,000→ 500,000 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2020-07-01−29,994→ 0 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2020-07-01$0.01/sh+29,994→ 193,258 total

Companies

Recent Filings

Address

C/O COHERUS ONCOLOGY, INC. 333 TWIN DOLPHIN DRIVE, SUITE 600

REDWOOD CITY, CA, 94065

View on SEC.gov